Best of the Week
Most Popular
1. Stock Markets and the History Chart of the End of the World (With Presidential Cycles) - 28th Aug 20
2.Google, Apple, Amazon, Facebook... AI Tech Stocks Buying Levels and Valuations Q3 2020 - 31st Aug 20
3.The Inflation Mega-trend is Going Hyper! - 11th Sep 20
4.Is this the End of Capitalism? - 13th Sep 20
5.What's Driving Gold, Silver and What's Next? - 3rd Sep 20
6.QE4EVER! - 9th Sep 20
7.Gold Price Trend Forecast Analysis - Part1 - 7th Sep 20
8.The Fed May “Cause” The Next Stock Market Crash - 3rd Sep 20
9.Bitcoin Price Crash - You Will be Suprised What Happens Next - 7th Sep 20
10.NVIDIA Stock Price Soars on RTX 3000 Cornering the GPU Market for next 2 years! - 3rd Sep 20
Last 7 days
Further Clues Reveal Gold’s Weakness - 26th Nov 20
Fun Things to Do this Christmas - 26th Nov 20
Industries that Require Secure Messaging Apps - 26th Nov 20
Dow Stock Market Trend Analysis - 25th Nov 20
Amazon Black Friday Dell 32 Inch S3220DGF VA Curved Screen Gaming Monitor Bargain Deal! - 25th Nov 20
Biden the Silver Bull - 25th Nov 20
Inflation Warning to the Fed: Be Careful What You Wish For - 25th Nov 20
Financial Stocks Sector ETF Shows Unique Island Setup – What Next? - 25th Nov 20
Herd Immunity or Herd Insolvency: Which Will Affect Gold More? - 25th Nov 20
Stock Market SEASONAL TREND and ELECTION CYCLE - 24th Nov 20
Amazon Black Friday - Karcher K7 FC Pressure Washer Assembly and 1st Use - Is it Any Good? - 24th Nov 20
I Dislike Shallow People And Shallow Market Pullbacks - 24th Nov 20
Small Traders vs. Large Traders vs. Commercials: Who Is Right Most Often? - 24th Nov 20
10 Reasons You Should Trade With a Regulated Broker In UK - 24th Nov 20
Stock Market Elliott Wave Analysis - 23rd Nov 20
Evolution of the Fed - 23rd Nov 20
Gold and Silver Now and Then - A Comparison - 23rd Nov 20
Nasdaq NQ Has Stalled Above a 1.382 Fibonacci Expansion Range Three Times - 23rd Nov 20
Learn How To Trade Forex Successfully - 23rd Nov 20
Market 2020 vs 2016 and 2012 - 22nd Nov 20
Gold & Silver - Adapting Dynamic Learning Shows Possible Upside Price Rally - 22nd Nov 20
Stock Market Short-term Correction - 22nd Nov 20
Stock Market SPY/SPX Island Setups Warn Of A Potential Reversal In This Uptrend - 21st Nov 20
Why Budgies Make Great Pets for Kids - 21st Nov 20
How To Find The Best Dry Dog Food For Your Furry Best Friend?  - 21st Nov 20
The Key to a Successful LGBT Relationship is Matching by Preferences - 21st Nov 20
Stock Market Dow Long-term Trend Analysis - 20th Nov 20
Margin: How Stock Market Investors Are "Reaching for the Stars" - 20th Nov 20
World’s Largest Free-Trade Pact Inspiration for Global Economic Recovery - 20th Nov 20
Dating Sites Break all the Stereotypes About Distance - 20th Nov 20
THE STOCK MARKET BIG PICTURE - Video - 19th Nov 20
Reasons why Bitcoin is Treading at it's Highest Level Since 2017 and a Warning - 19th Nov 20
Media Celebrates after Trump’s Pro-Gold Fed Nominee Gets Blocked - 19th Nov 20
DJIA Short-term Stock Market Technical Trend Analysis - 19th Nov 20
Demoncracy Ushers in the Flu World Order How to Survive and Profit From What Is Coming - 19th Nov 20
US Bond Market: "When Investors Should Worry" - 18th Nov 20
Gold Remains the Best Pandemic Insurance - 18th Nov 20
GPU Fan Not Spinning FIX - How to Easily Extend the Life of Your Gaming PC System - 18th Nov 20
Dow Jones E-Mini Futures Tag 30k Twice – Setting Up Stock Market Double Top - 18th Nov 20
Edge Computing Is Leading the Next Great Tech Revolution - 18th Nov 20
This Chart Signals When Gold Stocks Will Explode - 17th Nov 20
Gold Price Momentous ally From 2000 Compared To SPY Stock Market and Nasdaq - 17th Nov 20
Creating Marketing Campaigns Using the Freedom of Information Act - 17th Nov 20
ILLEGITIMATE PRESIDENT - 17th Nov 20
Stock Market Uptrend in Process - 17th Nov 20
How My Friend Made $128,000 Investing in Stocks Without Knowing It - 16th Nov 20
Free-spending Biden and/or continued Fed stimulus will hike Gold prices - 16th Nov 20
Top Cheap Budgie Toys - Every Budgie Owner Should Have These Safe Bird Toys! - 16th Nov 20
Line Up For Your Jab to get your Covaids Freedom Pass and a 5% Work From Home Tax - 16th Nov 20
You May Have Overlooked These “Sleeper” Precious Metals - 16th Nov 20
Demystifying interesting facts about online Casinos - 16th Nov 20
What's Ahead for the Gold Market? - 15th Nov 20
Gold’s Momentous Rally From 2000 Compared To Stock Market SPY & QQQ - 15th Nov 20
Overclockers UK Quality of Custom Gaming System Build - OEM Windows Sticker? - 15th Nov 20
UK GCSE Exams 2021 CANCELLED! Grades Based on Mock Exams and Teacher Assessments - 15th Nov 20

Market Oracle FREE Newsletter

How to Get Rich Investing in Stocks by Riding the Electron Wave

Trump's Unilateralism, China's Multilateralism and the Real COVID-19

Politics / Pandemic Nov 05, 2020 - 04:24 PM GMT

By: Dan_Steinbock

Politics

New estimates on actual COVID-19 cases in 2020 highlight the stark differences between the Trump administration’s unilateral stance, and China’s multilateral approach to overcoming the pandemic challenge.

The failed containment of the COVID-19 pandemic is about to result in 50 million cumulative confirmed cases and more than 1.2 million deaths around the world.

Worse, the official figures are only a tip of the iceberg. Some 10 percent of the world population may already have had the new coronavirus, according to the World Health Organization (WHO).

Consider the implications: That translates to 780 million people – almost 20 times the official total. The global stakes are far higher than currently acknowledged.


The official narrative                

The cumulative confirmed cases in the United States are about to surpass 10 million; in India and Brazil, 9 and 6 million, respectively. Meanwhile, several economies in the Americas and, once again, in Western Europe and Russia are coping with secondary waves.

At the end of October, the daily confirmed new cases remained highest in the US, where they were rising for the third time, and India, where they were falling (over 60,000 in each). The two were followed by Brazil, Argentina and Colombia, where cases were stagnating, and France, Russia and Spain, where they were climbing.

From March to early April, the first US wave peaked at some 32,000 daily cases. Daily numbers more than doubled to 67,000 during the second wave in June-July. As the third wave ensued after mid-September, those figures exceeded 70,000.

In Western Europe, countries that initially tested inadequately (France) or emulated US stance of minimal intervention (UK) have had peaks of  20,000 to 35,000, respectively. Countries that implemented broader interventions (Germany) are also coping with new peaks but the numbers are significantly lower (Figure 1).

Figure 1       Cumulative Confirmed COVID-19 Cases*

*  Rolling 7-day average.

Source: Data from European CDC; Difference Group, Oct 26, 2020

The unofficial narrative            

Policymakers use models to provide estimates of the true number of daily new infections. In these models, the projected actual infections far outnumber confirmed cases, although they differ by how and how much infections have changed over time. Here the focus will be here on (mean) estimates by Imperial College London (ICL) (Figure 2).

Figure 2       Projected “True” COVID-19 Cases*

* ICL = Imperial College London

Source: Data from Imperial College London; Difference Group, Oct 26, 2020

In this view, the early trendline was relatively highest in spring, due to high infectiousness and minimal testing. The peak of the US pandemic likely occurred in March-April when the projected daily cases peaked at about 600,000 (20 times higher than the official figure). The second wave caused another escalation to 190,000 cases (almost three times higher), while the current cases average around 110,000 (almost double the official figure).

In the UK and France, the first wave caused projected cases to soar to more than 170,000 and 115,000, respectively (4-5 times higher than the confirmed cases).

The stakes were arguably highest in China, which had to cope with the outbreak first. In the mainland, the daily confirmed cases soared to more than 4,000 in early spring. However, the projected daily count may have been closer to 124,000 (30 times higher than the confirmed figure). Yet, rapidly- and broadly-implemented quarantines bent the epidemic curve in just a few weeks, thanks to China’s reliance on science-based public-health measures.

If, instead, China had opted for the delays and denials of the Trump administration or the UK’s initial stance of not-so-benign neglect, such a scenario could have resulted in a global catastrophe, due to the world’s most populous nation, the peak travel season and the epicenter in the major transportation hub of Hubei.

Race for vaccines 

Since early spring, the vaccine race has been on among 180 candidates, over 40 of which are being tested in humans, especially by US, UK and Chinese drug giants.

Despite some challenges, Oxford University/ AstraZeneca (UK) hopes for a late fall 2020 release. Like AstraZeneca, Johnson & Johnson (US) had to temporarily stop trials after participants fell ill in the process. Following a delay of large-scale human testing with government regulators, Moderna (US) aims to start distribution in early 2021. Pfizer (US) has four vaccine candidates still in early-stage human trials, but two have been fast-tracked by US regulators.

In the meantime, China’s SinoVac is currently testing its vaccine on 10,000 volunteers in the mainland, 9,000 in Brazil and a smaller group in Indonesia; and the state-owned SinoPharm on 15,000 in the Middle East and Latin America.

Last July, the emergency use of experimental COVID-19 vaccines was authorized in China. In mid-October, the city of Jiaxing, south of Shanghai, began to offer a vaccine under development by Sinovac, focusing on medical and and other key groups. Having administered the drug to diplomats and workers traveling to Belt and Road countries, SinoPharm offered its drugs for free to students planning to study abroad (168,000 signed up).

SinoPharm is also conducting final Phase III trials for its two vaccine candidates in 10 countries.

In this pandemic, it’s the weakest links that shape the future. Medical and scientific experts in the West remain concerned about outcomes if people refuse to take the vaccines when they become available. According to new research, the willingness to take “a proven, safe and effective vaccine” is the highest in China (87%), but significantly lower in the West, particularly in Eastern Europe.

Failure of unilateral nationalism        

Launched in April by the WHO, France and the Gates Foundation, the COVID-19 acceleration mechanism (ACT) seeks to provide innovative and equitable access to diagnostics, treatments and vaccine.

As WHO chief Dr Tedros has warned, “vaccine nationalism will prolong the pandemic, not shorten it." To avoid such scenarios, over 180 countries are considering participation in COVAX, a global initiative to provide countries equitable access to vaccines. It is critical to lower-income countries, and vital to higher-income self-financing countries without bilateral deals with manufacturers.

Recently, WHO and Vaccine Alliance (GAVI) applauded China’s decision to join the COVAX. In contrast, the US has spurned the initiative, which aims to secure 2 billion doses of a safe and effective vaccine by the end of 2021.

As the projected estimates suggest, the stakes of the COVID-19 pandemic struggle and the broad implementations of mass vaccinations are multilateral and global challenges. Conversely, unilateral stances fuel new pandemic waves and delays in remedies.

Last April, amid the first COVID-19 wave in the US, President Trump sought to shift the blame by halting US funding to WHO. In May 2020, before the end of the review period, Trump declared that the US would “terminate” its relationship with WHO. The timing of these unilateral decisions by a major WHO funder threatened to undermine the world organization’s activities at the worst possible moment.

The global pandemic’s effects can only be overcome through multilateral international cooperation across all political differences. In the absence of such cooperation, those effects will only compound new, negative scenarios.

Dr. Dan Steinbock is the founder of Difference Group and has served at the India, China and America Institute (US), Shanghai Institute for International Studies (China) and the EU Center (Singapore). For more, see http://www.differencegroup.net/  

© 2020 Copyright Dan Steinbock - All Rights Reserved

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

Dan Steinbock Archive

© 2005-2019 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules